Cornea/External Disease News

Lions Eye Institute for Transplant and Research has entered into an agreement to acquire SightLife, according to a press release.

Proper protection from sunlight and ultraviolet rays is critical for eye health and vision, and the easiest and most effective way to achieve this is by wearing a good pair of sunglasses.

Novaliq submitted a new drug application to the FDA for CyclASol, a cyclosporine ophthalmic solution for the treatment of dry eye disease signs and symptoms, according to a company press release.

The first participant has been enrolled in a phase 2a clinical trial investigating TP-03 as a treatment for meibomian gland dysfunction in those with Demodex mites, according to a press release from Tarsus Pharmaceuticals.

The first subject has been dosed in the phase 3 registrational COMET-3 study investigating AR-15512 for the treatment of dry eye disease, according to a press release from Aerie Pharmaceuticals.

The term corneal allogenic intrastromal ring segments, or CAIRS, refers to the intra-channel placement of allogenic tissue for the treatment of corneal ectasia.

Although keratoconus can present at any age, most cases present between puberty and age 40 years.

Last month I shared my thoughts on where the winds were blowing as we look toward the near future of dry eye disease treatment.

Dry eye in Sjögren’s syndrome remains “underdiagnosed and undertreated,” and often not fully understood, according to Sjögren Europe, which is gearing up for World Sjögren’s Day on July 23 with a campaign aimed at raising awareness online.

Carl Zeiss Meditec and Precise Bio have partnered to develop and commercialize fabricated corneal tissue for endothelial keratoplasty and natural lenticule transplants to treat keratoconus and vision correction.